Ceva Santé Animale has gained a diversified portfolio of products from Boehringer Ingelheim following its acquisition of Merial Animal Health.

signature
Ceva Santé Animale has acquired a range of products for pigs, cattle and companion animals from Merial.

The suite of products includes swine and cattle vaccines and multi-species NSAIDs, namely:

  • Circovac (excluding US)
  • Progressis
  • Mucosiffa
  • Parvovax
  • Parvoruvax
  • Equioxx (excluding US)
  • Genixine
  • Ketofen 1% injection and tablets (excluding Canada)
  • Ketofen 10% injection (excluding Canada)

The divestiture did not include the transfer of a manufacturing site, but was implemented by means of a transfer of all relevant assets, Boehringer claimed.

No interruption

All products will be immediately available through local Ceva companies or its distributors, with no interruption of supply, the company said.

Ceva chairman and chief executive Marc Prikazsky said: “We are delighted to acquire this range of products and strong pipeline of R&D assets. The know-how behind these products dates from Pasteur, Rhone-Merieux, Merial and now as Ceva we are conscious we have a responsibility to maintain this strong veterinary scientific tradition.

“Our customers can be assured we will continue to invest to develop the products of both today and tomorrow.”

View your activity >

Leave a Reply

Be the First to Comment!

Notify of
avatar

wpDiscuz

related content

Ben Garland describes surgery to remove a foreign body from the oesophagus, looking at alternative methods, potential complications and recovery

26 mins

Mick Millar details his experience of examining a dead adult female African elephant.

13 mins

Following on closely from the first two parts of his February focus on gastric dilatation-volvulus, Gerardo Poli turns to surgery and offers a few pointers to help ensure the procedure runs as smoothly as possible.

8 mins

Celia Marr looks at the latest information surrounding diseases affecting equines and available analgesic options.

13 mins

Elisabetta Mancinelli discusses ocular disease in rabbits and rodents, and how the increasing number of research investigations is improving the standards of care.

13 mins

Peter Edmondson discusses why vets are best placed to help farmers make the transition to selective dry cow therapy.

27 mins